• No results found

REVIEWS. Current treatment landscape for relapsed and/or refractory multiple myeloma

N/A
N/A
Protected

Academic year: 2021

Share "REVIEWS. Current treatment landscape for relapsed and/or refractory multiple myeloma"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 | Regional indications for immunomodulatory drugs and proteasome inhibitors for MM  Agent Europe (http://www.emea.europe.eu) USA (http://www.fda.gov) Thalidomide Combination with melphalan and prednisone to treat
Table 3 | Treatment recommendations for patients with relapsed MM
Table 6 | Treatment recommendations for patients with relapsed and refractory MM

References

Related documents

It is significant that the types of context excavated at each site differed: thus, burial sites or tombs were excavated at Alishar Höyük and Kültepe;

We presented new preliminary results in studying the flux tube produced by a quark-antiquark pair in the case of SU(3) pure gauge theory across the deconfinement phase transition.. 8

According to the International Diabetes Federation (IDF) de fi nition, MetS was de fi ned in case of WC ≥ 94 cm in men and ≥ 80 cm in women (all participants were Caucasians and

informatieverschaffing en het recht van voorkoop”, T. VAN HOORICK, Handboek Ruimtelijk Bestuursrecht , Antwerpen, Intersentia, 2011, p. VAN HOORICK, Handboek Notarieel

ontwerpbeslissing uitgewerkt staat. Dit omdat iedere scope wijziging gevolgen kan hebben voor de kosten, kwaliteit en doorlooptijd van het project. De doelstelling van dit

The cross-polarized patterns of the fabricated antennas are also measured in both E and H -planes; however, since the maximum measured cross-pol gain of the antennas is approximately

Regarding this, we decided to investigate the relationship of the mental health with academic performance and some demographic factors among the students of medical sciences in

A simple, precise, accurate, rapid and economical spectrophotometric method requiring no prior separation have been developed for simultaneous estimation of Atorvastatin